NS
Neeraj Singh Ranawat
About Neeraj Singh Ranawat
Data last updated:
Neeraj Singh Ranawat is a Designated Partner at Abrogate Pharma Llp (since 2020), Director at Oraltab Healthcare Private Limited (since 2018) and Director at Abrogate Healthcare Private Limited (since 2018). The companies operate in Chemicals and Pharma. The largest current company by reported revenue is Abrogate Pharma Llp at ₹67.1 Lakh (FY 2022). Earlier, Neeraj Singh Ranawat was a Director at Uniclip Healthcare Private Limited (from 2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 21 Aug 2020 | 2020 | ₹67.1 Lakh (FY 2022) | Active | |
| Director | 10 Sep 2018 | 2018 | Active | ||
| Director | 11 Apr 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Oct 2014 | 2014 | ₹1.9 Lakh (FY 2018) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Neeraj Singh Ranawat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vishali Swami | 08940404 | Abrogate Pharma Llp | Designated Partner |
| Ram Lakhan Disania | 07220533 | Oraltab Healthcare Private Limited , Abrogate Healthcare Private Limited | Director |
| Manohar Lal Kanwaria | 08437946 | Abrogate Healthcare Private Limited | Director |
| Pawan Kumar Sharma | 08437984 | Abrogate Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neeraj Singh Ranawat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neeraj Singh Ranawat
Neeraj Singh Ranawat currently holds 3 directorships: Abrogate Pharma Llp (Designated Partner, since 21 Aug 2020, revenue ₹67.1 Lakh (FY 2022)); Oraltab Healthcare Private Limited (Director, since 10 Sep 2018); Abrogate Healthcare Private Limited (Director, since 11 Apr 2018).
Neeraj Singh Ranawat was first appointed on 22 Oct 2014 as Director at Uniclip Healthcare Private Limited. The most recent appointment on record is 21 Aug 2020 at Abrogate Pharma Llp.
Neeraj Singh Ranawat held 1 earlier board appointment: Uniclip Healthcare Private Limited (Director, from 22 Oct 2014).
The current boards of Neeraj Singh Ranawat's companies include Vishali Swami (Abrogate Pharma Llp), Ram Lakhan Disania (Oraltab Healthcare Private Limited), Manohar Lal Kanwaria (Abrogate Healthcare Private Limited), Pawan Kumar Sharma (Abrogate Healthcare Private Limited).